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ABSTRACT 
 
This chapter addresses the different methods used to diagnose 
brucellosis. Rapid diagnosis of the disease is essential for its control and 
to protect public health. Basically, there are two types of tests, the direct 
tests, which detect the presence of Brucella and are used in clinical 
situations where the animals are affected and show clinical signs, and 
indirect tests that are mainly used for screening to detect subclinical 
conditions. These are widely used as part of control and eradication 
programs. Main aspects of direct tests are described, namely bacterial 
isolation and identification and molecular methods: conventional and 
real-time PCR, multiple locus variable-number tandem repeat analysis, 
multi-locus sequence typing and luminex xMAP technology. Regarding 
indirect tests, serological tests are prefered: milk ring test, buffered 
Brucella antigen tests, namely rose Bengal test and buffered plate 
agglutination test, serum agglutination test, complement fixation test, 
indirect and competitive enzyme-linked immunosorbent assays, 
fluorescence polarization assay, immunoprecipitation tests and lateral 
flow immunochromatography. Another indirect test, interferon-gamma 
release assay, performed on whole blood and brucellin skin tests are 
discussed. Concerning sensitivity (DSe) and specificity (DSp) of the 
methods, none of the tests are Brucella species-specific, but some of 
those, specifically the buffered agglutination tests, set a high standard 
with regards to the DSe/DSp. Although no current serological test 
provides enough DSe for the 100% DSp required, some test combinations 
can be of great help.  
 
Keywords: bacterial methods, direct tests, indirect tests, molecular 
methods, serological methods 
 
 
INTRODUCTION 
 
To control and eradicate brucellosis is extremely important to 
diagnose it promptly and accurately. Brucellosis diagnostic tests fall into 
two categories: those that demonstrate the presence of organisms and those 
that detect an immune response to their antigens. 
In ruminants, flock identification of the disease depends on the 
presence of clinical manifestations such as reproductive failure, i.e., 
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abortion and birth of weak offspring in females, and orchitis and 
epididymitis in males. Brucellosis identification, in one or more infected 
animals, is sufficient evidence that the infection is present and, therefore, 
other animals may be incubating the disease and present a risk (Garin-
Bastuji et al., 1998; Corbel, 2006).  
The laboratory diagnosis of brucellosis can be based on direct and 
indirect methods and should be performed whenever clinical signs or 
epidemiological evidences suggestive of the disease are observed. 
Accurate diagnostic and standard procedures are critical for the success of 
the brucellosis control and eradication. Furthermore, the identification of 
the different species is of great epidemiological importance. In the 
European Union, according to Directive 2003/99/EC, brucellosis and its 
agents are included within the list of zoonosis that requires surveillance.  
Several biological samples can be used for monitoring and laboratory 
confirmation of the Brucella spp. infection. The collected samples can be 
examined fresh or frozen and transported to the laboratory. Samples of 
milk, vaginal swabs, blood, aborted materials (aborted fetus, fetus 
membranes) and carcasses may be used (Alton et al., 1975). 
The differentiation between Brucella species and their different 
biovars has been based on serotyping, phage typing, sensitivity to dyes, 
CO2 requirement, H2S production, and metabolic properties. However, the 
variability of some phenotypic characteristics in different Brucella strains 
impairs the identification of species and biovars. Therefore, the design of 
stable markers based on DNA is presently considered essential for the 
detection and identification of Brucella. 
Indirect diagnosis methods are widely routinely used in control and 
eradication and surveillance programs for ruminants. Immunological tests 
are required at each step of intervention against brucellosis: the evaluation 
of the prevalence, the assessment of the efficacy of control and elimination 
measures, and the confirmation of erradication of disease through 
surveillance (Ducrotoy et al., 2018). For human brucellosis diagnosis, as 
the Brucella organism grows very slowly in vitro, serological tests are used 
as screening tests for preliminary diagnosis of brucellosis (Khan et al., 
2017).  
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DIRECT DIAGNOSIS 
 
As mentioned before, brucellosis direct diagnostic tests are based on 
bacterial isolation and identification, and molecular methods. Cultural 
methods are time-consuming and costly. Molecular methods, on the other 
hand, have been increasingly applied for the diagnosis of infection in 
human and in veterinary medicine. In particular, Polymerase Chain 
Reaction (PCR)-based methods, have been used successfully for this 
purpose. When compared to bacteriological isolation those methods are 
advantageous for its speed, sensitivity and safety. In fact, molecular 
methods allow rapid diagnosis and differentiation of various bacterial 
species, especially slow-growing ones. 
According to OIE Terrestrial Manual (OIE, 2016), there is no single 
test by which a bacterium can be identified unequivocally as Brucella. A 
combination of growth characteristics, serological, bacteriological or 
molecular methods is required for a definitive identification. 
 
 
Bacteriological Methods 
 
Isolation and identification of the etiologic agent is an unequivocal 
method of diagnosis of brucellosis. It is relatively sensitive when 
performed in skilled and experienced laboratories. 
The classical microbiological identification of brucellae strains is 
based on colonial morphology, microscopic appearance and biochemical 
properties, such as CO2 requirement, H2S production, urea hydrolysis, 
sensitivity to basic fuchsin and thionin, and also agglutination with 
monospecific sera, and phagetyping (Alton et al., 1988). For bacterial 
culture, samples from uterine discharges, aborted fetuses, udder secretions 
or selected tissues, such as lymph nodes and male and female reproductive 
organs, should be aseptically taken and immediatly cooled or frozen if they 
are to spend more than 12 hours before being cultured. 
Before culturing, smears of organs or biological fluids may be 
performed and stained after fixed with heat or ethanol. Brucellae are Gram 
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negative coccobacilli that usually do not show bipolar staining and stain 
red by the Stamp’s modification of the Ziehl–Neelsen’s method (OIE, 
2016). 
Direct isolation and culture of Brucella are usually performed on solid 
media. Different basal media supplemented with 2–5% bovine or equine 
serum, with or without appropriate antibiotics to suppress the growth of 
contaminant organisms, may be used. After a 4-day incubation at 37°C ± 
2°C in air supplemented with 5–10% (v/v) CO2, brucellae colonies appear 
as round, 1–2 mm in diameter, with smooth margins, translucent and pale 
honey coloured when observed through a transparent medium and convex 
and pearly white when viewed from above. These colonies may undergo 
variation during growth and develop rough forms. 
For identification, characteristic colonies (both smooth and rough 
colonies) should be examined using a Gram or Stamp stained-smear, and 
urease and oxidase tests, the slide agglutination test with a polyclonal anti-
Brucella serum. Species and biovar identification relies on the CO2 
requirement for growth, production of H2S, growth in the presence of basic 
fuchsin and thionin, phage lysis and agglutination with monospecific sera. 
As dyes and phage sensitivity are usually altered in the non-smooth phases, 
attention to the colonial morphology is essential for the correct 
interpretation of typing tests (OIE, 2016). 
 
 
PCR Assay 
 
PCR amplification of specific DNA regions have been successfully 
used for Brucella identification and typing. 
The first PCR-based method has been directed toward detection of a 
single unique genetic locus that is common among all species of Brucella, 
such as 16S and 23S rRNA operon, IS711 insertion sequence or bcsp31 
gene. PCR techniques have been developed directed toward detection of 
gene loci, that are variable among the species/biovars (Çiftci et al., 2017). 
PCR primers could be used to screen the Brucella spp., but the sensitivity 
of the test for bacterial detection in blood and milk is low, mainly due to 
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the difficulty of lysing the microorganisms. In B. abortus two copies of 
DNA sequence of the gene coding for omp2 were described. Furthermore, 
studies have shown that for the detection B. abortus, in blood and milk 
samples, primers for both copies are required (Ficht et al., 1989; Leal-
Klevezas et al., 1995).  
The IS711 insertion sequence is unique to Brucella species, and its 
copy number in the genome varies between species and biovars. Thus, the 
amplification of this mobile element is used to differentiate between 
species, producing band sizes with 731 bp (B. melitensis), 498 bp (B. 
abortus), 285bp (B. suis), 976 (B. ovis) (Çiftci et al., 2017). Based on the 
observation that this genetic element occurs at several species-specific or 
biovar-specific chromosomal loci, Brickera and Halling (1994) developed 
a PCR protocol, AMOS (Abortus-Melitensis-Ovis-Suis)-PCR, designed to 
amplify species-specific-sized products by using five primers, one of 
which hybridizes to the IS711 element and the others hybridize to one of 
four species-specific regions adjacent to the element. Identification was 
based on the products’ size of resulting amplicons. The performance of the 
assay, for field isolates, was highly effective, allowing the differentiation 
of B. abortus (1, 2, and 4), B. melitensis (biovars 1, 2 and 3), B. suis biovar 
1, and B. ovis. However, this AMOS -PCR was not able to differentiate all 
subspecies. Later, new oligonucleotide primers have been added to the 
AMOS-PCR multiplex allowing the discrimination between B. abortus 
vaccine strains (S19 and RB51) and wild-type isolates (Bricker and 
Halling, 1995). An improvement of this AMOS-PCR format was later 
performed by Ocampo-Sosa and colleagues (2005) in order to discriminate 
B. abortus biovars 3b, 5, 6 and 9 (Bricker and Halling, 1995; Ocampo-Sosa 
et al., 2005). 
Also using as target the multiple insertion element IS711, which is 
stable in both number and position in the Brucella chromosomes, Hinić et 
al. (2008) designed seven primer pairs for individual reactions for the rapid 
detection of the Brucella genus, and the differentiation between B. 
melitensis, B. abortus, B. suis, B. ovis, B. canis, and B. neotomae. Lysates 
from 18 reference and 47 Brucella field strains were analyzed and each of 
the PCR reactions generated a specific PCR product, which correlated in 
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all cases to the corresponding Brucella species, while non-Brucella species 
showed no amplification with any of the primers. 
To increase the sensitivity of the conventional PCR methods for 
tissues, it is necessary to optimize PCR and DNA extraction protocols. In a 
recent study on aborted sheep and bovine fetuses, Çiftci et al. (2017), using 
different target genes for B. melitensis (Ba148/928, 31ter/sd, IS711, 
JPF/JPR, and F4-R2) and for B. abortus (Eri1-Eri2 genes), showed higher 
sensitivity in tissues, blood, milk and semen, when compared with 
conventional bacteriological isolation, using different conditions of PCR 
protocols optimization.  
Currently, the Bruce-ladder multiplex PCR is the most commonly used 
method for the differentiation of the majority of Brucella species and S19, 
RB51, and Rev.1 vaccine strains and the identification is based on the 
numbers and sizes of seven products amplified by the PCR. In a study 
including 625 Brucella isolates from different geographic origins and 
different animal species, including humans, Bruce-ladder showed to be 
species-specific. Nevertheless, this PCR assay cannot differentiate among 
biovars from the same species (García-Yoldi et al., 2006; López-Goñi et 
al., 2008). Lopez-Goñi et al. (2011) developed a multiplex PCR (Suis-
ladder) that, besides the differentiation of B. suis, B. canis and B. microti, 
is able to differentiate the five biovars of B. suis.  
 
 
Real-Time PCR Assay 
 
The Real-Time PCRs for species differentiation are based on unique 
genetic loci and provides a means of detecting and quantifying DNA 
targets by monitoring PCR product accumulation during cycling by 
increased fluorescence. Different PCR protocols were optimized for 
Brucella spp. detection. Newby et al. (2003) designed a pair of primers and 
respective hybridization probes for B. abortus to produce a 156-bp 
amplicon spanning a region of the genome that includes portions of the 
alkB gene and the IS711 insertion element, which is highly specific to 
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detect this species, using a particular protocol, but not aplicable for other 
Brucella spp. 
A protocol, named TaqMan® real-time PCR assay, was designed, 
optimized and evaluated for the detection of Brucella at genus level by 
targeting a conserved region of three specific genes: (i) the insertion 
sequence IS711, (ii) bcsp31 and (iii) per genes. It presented several 
advantages over conventional PCR when used for B. ovis, B. melitensis bv. 
1, B. abortus bv. 1 and B. canis reference strains. This protocol showed to 
be less labourious, faster and uses a closed system with no need of post-
PCR handling, preventing DNA contamination (Bounaadja et al., 2009).  
Doosti and Moshkelani (2011) developed a real time PCR assay for 
identification and species differentiation of B. melitensis and B. abortus 
from mice tissue, targeting B. melitensis BMEII0466 gene and B. abortus 
BruAb2_0168 gene. Real time PCR showed higher specificity over gel 
electrophoresis. Similar results were obtained, with the IS711 gene, using 
different primers, for simultaneous detection and differentiation of the 
species of B. abortus and B. melitensis (Mirnejad et al., 2012). Primers 
targeting the multiple insertion element IS711, may be used with 
corresponding TaqMan® probes, for real-time PCR assay for the 
identification of the Brucella genus, as well as the differentiation between 
B. melitensis, B. abortus, B. suis, B. ovis, B. canis, and B. neotomae (Hinić 
et al., 2008). 
To improve the specificity of the analysis methodologies, real time 
PCR followed by High-Resolution Melt (HRM) was developed. This 
molecular technique utilizes curve analysis to reliably type members of the 
Brucella genus, using a panel with seven primer sets to identify species 
and respective biovars. Gene target and corresponding Brucella species 
were vdcc (Brucella spp.), int-hyp (B. canis, B. suis bv3 and bv4), 
BP26/IS711 (marine species), int-hyp (B. melitensis), glk (B. neotomae), 
Transposase gene (B. suis) and glk (B. ovis and B. abortus). Results 
showed >99% accuracy compared to traditional techniques, based on 153 
Brucella spp. isolates (Winchell et al., 2010). 
The advantages of real-time PCR are speed (since there is no need to 
analyze the PCR products by agarose gel electrophoresis), higher 
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sensitivity, and specificity for the detection of the Brucella species in 
clinical samples when compared with conventional PCR. However, 
protocols should be carefully validated on a representative numbers of 
Brucella infected samples and Brucella free controls before being 
implemented in routine diagnosis for animal and human brucellosis 
(Bounaadja et al., 2009). 
 
 
Multiple Locus Variable-Number Tandem Repeat Analysis 
(MLVA) and Multi Locus Sequence Typing (MLST) 
 
MLVA is based on the analysis of variable number-tandem repeats 
(VNTR), which exists in bacterial genomes and seems to be highly 
discriminatory markers, even when the pathogens investigated belong to 
monomorphic species with high similarity, such as Brucella spp. (DNA–
DNA homology >90%) (AI Dahouk et al., 2007; Kiliç et al., 2011). 
Tandem repeats are copies of an elementary unit into the genome and can 
be observed in different bacterial strains. Tandem repeats are classified in 
satellites (megabases of DNA) present in many eukaryotic genomes, 
minisatellites (spanning hundreds of base pairs with a repeat unit size of at 
least 9 bp), and microsatellites (spanning a few tens of nucleotides with a 
repeat unit size 2-6 bp) (Denœud and Vergnaud, 2004; Le Flèche et al., 
2006; Sweet et al., 2012). 
The most used MLVA genotyping system for brucellosis is MLVA-16, 
originally developed by Le Flèche et al. (2006) and modified by Al 
Dahouk et al. (2007), which consists of 16 genetic markers (MLVA-16) 
comprising eight minisatellite markers most appropriate for species-level 
identification (panel 1-Bruce06, Bruce08, Bruce11, Bruce12, Bruce42, 
Bruce43, Bruce45, and Bruce55), and eight microsatellite markers with 
higher discriminatory power (panel 2A-Bruce18, Bruce19, and Bruce21; 
panel 2B-Bruce04, Bruce07, Bruce09, Bruce16, and Bruce30). Based on 
simple PCR reactions, MLVA-16 is accessible and the number of alleles 
(PCR amplicons) can be analyzed by simple agarose gel electrophoresis or 
automatic high-throughput procedures. Even tandem repeats differing by a 
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single repeat unit can be distinguished by these methods. MLVA 
genotypes can correlate with the geographic origin of the strains, 
comprising a tool for molecular epidemiological studies of brucellosis. 
MLVA is a reliable method of monitoring phylogeny of the lineage 
and the regional and temporal distribution of the disease. Results are 
strengthened when a larger number of strains are included in the analysis 
(AI Dahouk et al., 2007; Ficht, 2010; Ferreira et al., 2017). In this way, a 
collaborative public online database, based on a MLVA-16 scheme, has 
been built up with the aim of promoting the creation of a global 
epidemiological map of Brucella spp. (Brucella MLVA database at 
http://mlva.u-psud.fr/), where genotypes can be submitted and compared to 
other published results.  
According to required test specificity, MLVA can be performed using 
the 16 loci (MLVA-16; panels 1 and 2 markers), using 11 loci (MLVA-11; 
panels 1 and 2A markers) or using eight loci (MLVA-8; panel 1 markers) 
(Le Flèche et al., 2006; AI Dahouk et al., 2007; Kiliç et al., 2011; Ferreira 
et al., 2017). 
The MLVA-16 and MLVA-11 were used for investigating the 
epidemiological relationship and genetic diversity of human B. melitensis 
isolates, collected in Turkey regions. Results showed that the most 
prevalent MLVA genotype is typically B. melitensis biovar 3, frequently 
isolated in humans and common in the East Mediterranean region (Kiliç et 
al., 2011). The same biovar 3 B. melitensis was also found in a human 
epidemiological study in China (Xiao et al., 2015), with genotypic profiles 
from different countries, such as Israel, Irac, Lebanon and Syria. These 
results highlight the importance of quarantine rules, suggesting that poor 
importation quarantine policies may account for a set of B. melitensis 
infections. 
This method has been widely used to study genotype distribution of 
Brucella isolates, such as B. canis (Di et al., 2014), marine mammal 
isolates, B. ceti and B. pinnipedialis (Maquart et al., 2009), B. suis 
(Ferreira et al., 2017), B. melitensis in Italy (De Massis et al., 2015) and in 
Mongolia (Kang et al., 2017). Recently a MLVA-13Bc assay was 
developed and validated using a combination of 13 VNTRs specifically 
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designed for genotyping B. canis strains, with high discriminatory power 
(Yang et al., 2017). 
The MLVA assay is rapid, highly discriminatory, and reproducible 
within human Brucella isolates (Al Dahouk et al., 2007). This technique is 
useful for analysis of Brucella spp., in especially B. melitensis, the most 
pathogenic for humans. Molecular typing methods improve epidemio-
logical surveillance efficiency, determine pathogenic relationships and 
trace-back brucellosis for potential risk factors (season, rearing system, 
product, and environment condition) of outbreak regions (Kang et al., 
2017). Studies based on MLVA are helpful to understand the dynamic 
distribution of brucellosis in the world and can improve the prevention, 
surveillance, and management of brucellosis in neighbouring countries, 
and countries involved in trade and distribution of animal species at risk of 
brucellosis. 
MLST has been used to identify the species and genotypes of these 
Brucella isolates (Ma et al., 2016). MLST is a DNA sequence-based typing 
method for many different bacterial species to differentiate strains and 
identify clonal lineages. The procedure characterizes isolates using the 
DNA sequences of multiple genetic loci, usually but not exclusively 
housekeeping genes, which are then accurately sequenced on both strands 
using an automated DNA sequencer. For each gene, the different 
sequences are assigned as alleles and the alleles at the loci provide an 
allelic profile or sequence type (ST). A series of profiles can then be the 
identification marker for strain typing and characterizes strains by their 
unique allelic profiles. Whatmore et al. (2007) amplified by PCR nine 
distinct genome fragments. Products were separated by agarose gel 
electrophoresis; PCR products were then purified and sequenced. Each 
unique allelic pattern over all nine loci was identified as a ST. Sequences 
of the nine loci were concatenated to produce a 4,396 bp sequence for each 
genotype. Phylogenetic analysis was performed with software, and 
neighbour joining trees were constructed. These authors stated that the 
sequencing of these nine fragments is a potentially valuable tool for the 
identification of Brucella. 
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To improve the resolution of MLST for Brucella, an extended MLST 
(EMLST) by increasing the sequencing length was described by Chen et al. 
(2011). Through analysis of a large number of sequence data was possible 
to improve resolution of MLST. These authors found that the EMLST 
method could increase the length by about 50%. With the increased 
sequences, more alleles and STs were identified, and the genotyping 
resolution of the MLST was greatly improved.  
 
 
Luminex xMAP Technology 
 
Luminex xMAP system is a multiplexed microsphere-based 
suspension array platform capable of analyzing and reporting up to 100 
different reactions in a single reaction vessel by performing discrete assays 
on the surface of colour-coded beads known as microspheres, which are 
then read in a compact analyzer (Dunbar, 2006). This technology may be 
used for high-throughput nucleic acid detection methods. For that purpose, 
DNA probes to detect PCR amplicons are covalently coupled to the 
microspheres (Dunbar et al., 2003). The Luminex® xMAPTM System has 
the advantage that they allow for simultaneous detection of multiple 
nucleic acid sequences in a single reaction vessel which reduces time, 
labour and cost as compared to single-reaction-based detection methods. 
Pfefer et al. (2018) developed a multiplexed assay called Luminex 
bead-based suspension array for detection and identification of the most 
common Brucella species (B. abortus, B. melitensis, B. suis, B. suis bv5, B. 
canis, B. ovis, B. pinnipedialis, and B. neotomae) as well as the Brucella 
genus level. The work demonstrated overall excellent accuracy for all 
strains tested and the platform also allows for flexibility in assay design to 
easily add more Brucella species and to attain excellent target accuracy due 
to the customization of both primers and probe. 
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INDIRECT DIAGNOSIS 
 
Indirect methods, or immunological methods, detect an immune 
response to Brucella antigens. They are mostly used for simplicity of 
execution and interpretation and are based on antibody detection. The 
detection of these Brucella-specific antibodies in milk or serum samples 
may be performed through numerous immunological diagnostic tests, 
including milk ring test (MRT), buffered Brucella agglutination tests (i.e., 
Rose Bengal test (RBT); Card Test (CT), and buffered plate aglutination 
test (BPAT), complement fixation test (CFT), enzyme-linked immune-
sorbent assay (ELISA) and fluorescence polarisation assay (FPA). Most of 
them do not have high sensitivity and specificity and it is usually necessary 
to associate several techniques to increase the level of detection (Garin-
Bastuji et al., 2006). 
Indirect tests are used worldwide for screening of herds/flocks and 
individual small ruminants, camelids and bovines, to contribute to 
eradication policies and to study herd/flock prevalence of infection and 
surveillance (OIE, 2016). The World Organisation for Animal Health 
(OIE) emphasizes that no single serological test is appropriate in all 
epidemiological situations, since all have limitations, especially when it 
comes to screening individual animals or humans. 
B. abortus strain 99 (Weybridge) (S99), B. abortus strain 1119-3 
(USDA) (S1119-3) or B. melitensis strain 16M are used for the production 
of antigens for different serological tests. These bacterial cells may be used 
either as all cell antigen or as a source of soluble antigen extracts as 
smooth lipopolysaccharide (S-LPS) or O-polysaccharide (OPS). The 
Brucella OPS represents the most immunogenic bacterial portion (Olsen 
and Palmer, 2014; OIE, 2016).  
The list of available tests for the diagnosis of infection with smooth 
Brucella species, in particular B. abortus, B. melitensis and B. suis, are 
available on the OIE Web site (http://www.oie.int), in the Manual of 
Diagnostic Tests and Vaccines for Terrestrial Animals (Table 8.1). The 
most used tests are the buffered Brucella agglutination tests (BBAT; i.e., 
RBT, BPAT) CFT, FPA and indirect or competitive enzyme-linked 
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immunosorbent assays (I-ELISA and C-ELISA, respectively) (CFSPH, 
2009; OIE, 2016). 
 
Table 8.1. List of brucellosis diagnostic tests: the “prescribed tests” are 
required by the OIE Terrestrial Animal Health Code for the 
international movement of animals and animal products; and 
“alternative tests” are suitable for the diagnosis of disease within a 
local setting and can also be used in the import/export  
of animals after bilateral agreement 
 
Disease name Prescribed tests Alternative tests 
Bovine brucellosis  
(B. abortus and B. melitensis) 
BBAT, CFT, ELISA, 
FPA, SAT 
BBAT+NH, MRT, IFN-γ 
Caprine and ovine brucellosis 
(excluding B. ovis) 
BBAT, CFT Brucellin test, FPA, NH 
Ovine brucellosis (B. ovis) CFT ELISA 
Swine brucellosis (B. suis) ELISA BBAT, FPA 
Abbreviations: buffered Brucella antigen test (BBAT); complement fixation test (CFT); enzyme-linked 
immunosorbent assay (ELISA); fluorescence polarisation assay (FPA); serum agglutination test 
(SAT); native hapten test (NH); milk ring test (MRT), interferon gama (IFN-γ). 
Adapted from OIE (2008, 2018) 
 
 
Milk Ring Test (MRT) 
 
In lactating cattle, the Milk ring test (MRT) can be used for screening 
herds for brucellosis. However, the MRT is not suitable in milk from small 
ruminants (OIE, 2016). 
The test consists of mixing coloured Brucella haematoxylin-staining 
whole-cell antigen with fresh bulk/tank milk. In the presence of anti-
Brucella antibodies, antigen-antibody complexes form and migrate to the 
cream layer, forming a dark blue ring on the surface, as fat globules adsorb 
the immunoglobulins by their Fc fractions and act as passive carriers 
promoting an effective clumping of brucellae. In the absence of antigen-
antibody complexes, the suspension remains uniform and the cream 
remains colorless. This test is not considered sensitive but this lack of 
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sensitivity is compensated by the fact that the test can be repeated, usually 
monthly, due to its very low cost (OIE, 2009).  
 
 
Buffered Brucella Antigen Tests (BBAT) 
 
Buffered Brucella antigen tests are simple spot agglutination tests 
using stained antigen. These include the Rose Bengal test (RBT) and the 
buffered plate agglutination test (BPAT). 
Agglutination tests are the most widely used serological tests, for 
screening purposes as they give specific and reliable preliminary diagnosis, 
and are cost effective (Naik et al., 2017). 
 
 
Rose Bengal Agglutination Test (RBT) 
 
The RBT is a simple method of brucellosis diagnostics and is the most 
widely used for the serological diagnosis of sheep and goat brucellosis. 
RBT is performed with a stained B. abortus suspension at pH of 3.6-3.7. 
RBT consists of a simple spot agglutination test where drops of rose 
Bengal-stained antigen and serum are mixed on a plate and any resulting 
agglutination signifies a positive reaction (Alton et al., 1988). The RBT is 
an affordable, quick, simple and efficient screening test and is used as a 
diagnostic test for screening individual animals and herds, as well as in 
humans. This test was found efficient in diagnosis of the acute human 
brucellosis and still is used in the diagnosis of chronic cases. Normally, 
results are obtained in few minutes (Khan et al., 2017; Teng et al., 2017).  
Although rapid and excellent for screening, this test is not reliable for 
vaccinated animals, because it can generate false positives due to its high 
sensitivity (Smirnova et al., 2013). It is conventional that RBT have little 
specificity in animals and humans that are already immunized with strain 
19. Therefore, a positive blood sample should be confirmed by definitive 
test. In fact, in most countries, the RBT is mostly used as a screening test, 
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followed by the CFT as a confirmatory test for diagnosis of brucellosis 
(Khan et al., 2017). 
 
 
Buffered Plate Agglutination Test (BPAT) 
 
The BPAT is also a spot agglutination test where a stained B. abortus 
antigen is used. Two staining solutions are required: brilliant green (2 
g/100 mL) and crystal violet (1 g/100 mL) mixed together in equal 
volumes to prepare a stained-cell suspension with a blue–green color. This 
antigen is mixed on a plate with serum and any resulting agglutination 
signifies a positive reaction (OIE, 2016). 
 
 
Serum Agglutination Test (SAT) 
 
The SAT has been used with success for many years in surveillance 
and control programs for bovine brucellosis. The first serological test for 
brucellosis, was described in 1897 and it was based on the sedimentation 
of the complexes of IgM antibodies with B. abortus antigens (Wright and 
Smith, 1897). The reaction is slow since it requires an overnight incubation 
at 37˚C. SAT, lacks specificity and sensitivity, although it is inexpensive 
and easy to perform. This test is only appropriate for cattle (OIE, 2016). 
 
 
Complement Fixation Test (CFT)  
 
The CFT detects anti-Brucella antibodies that are able to activate the 
complement. The complement system consists of a complex series of 
proteins, which, if triggered by an antigen-antibody complex, react in a 
sequential manner to cause cell lysis (Hill, 1963). This test is widely used 
but it is complex to perform and requires good laboratory facilities and 
adequately trained staff to accurately titrate and maintain the reagents. 
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There are numerous variations of the CFT in use, but this test is most 
conveniently carried out in a microtitre format. 
The CFT is usually very specific but less sensitive than RBT and 
ELISA and the absence of anti-complementary activity must be checked 
for each serum. Moreover, like most serological tests, the CFT can show 
positive results in ruminants after B. abortus S19 or B. melitensis Rev.1 
vaccination and it is not specific enough in the presence of false positive 
serological reactions (FPSR). Therefore, CFT results should be 
investigated using suitable confirmatory or complementary strategies (OIE, 
2016). 
 
 
Indirect Enzyme-Linked Immunosorbent Assays (i-ELISA) or 
Competitive Enzyme-Linked Immunosorbent Assay (c-ELISA)  
 
Serological tests like ELISA are capable of readily identifying 
individual IgM and IgG antibody allowing for a better correlation with the 
clinical situation (Naik et al., 2017). ELISA is recommended for screening 
cattle as well as humans due to its sensitivity and specificity compared 
with RBT (Khan et al., 2017). 
The i-ELISA was developed originally to allow large-scale assaying of 
antibodies in bovine serum and milk. Most i-ELISA use purified smooth 
LPS as the antigen, but a good deal of variation exists in the anti-bovine Ig 
conjugate used to detect mainly IgG or IgG sub-classes. Their best quality 
is their high sensitivity but they are also more vulnerable to non-specific 
reactions (McGiven et al., 2003; Saegerman et al., 2004). The diagnostic 
sensitivity should be equal to, or greater than that of the BBATs 
(RBT/BPAT), or the CFT when testing infected cattle, small ruminants or 
pigs. However, the specificity may be lower (Praud et al., 2012). 
These cross-reactions seen in i-ELISA led to the development of c-
ELISA. The c-ELISA for detection of specific antibodies has largely 
replaced the i-ELISA for large-scale screening and serosurveillance. In this 
method, sample antibody competes for binding to antigen bound to 
microtiter plate wells with a limited amount of labeled antibody. The 
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higher the sample antibody concentration, the weaker the output signal, 
indicating that the signal output inversely correlates with the amount of 
antigen in the sample. The c-ELISA offers significant advantages over the 
indirect assay since samples from many species may be tested without the 
need for species-specific enzyme-labelled conjugates for each species 
under test. Besides, c-ELISA reduces, but not fully eliminates, the 
reactions caused by antibodies produced in response to vaccination. It is 
highly probable that much of the specificity improvement is due to a 
reduction in sensitivity of the c-ELISA compared with BBAT and i-
ELISA. (OIE, 2016). 
 
 
Fluorescence Polarization Assay (FPA) 
 
The FPA is a homogeneous assay in which analytes are not separated 
and it is therefore very rapid. It is a simple technique for measuring 
antigen/antibody interaction and may be performed in a laboratory setting 
or in the field. This method is based on a physical principle: how quickly a 
molecule spins in a liquid medium correlates with its mass. Molecules of 
small size spin faster and depolarize a polarized light beam more, while 
bigger molecules spin more slowly and, consequently, depolarize light less. 
FPA measures the degree of depolarization in milli-polarization units (mP). 
During the test, serum samples are incubated with a specific antigen of B. 
abortus labeled with fluorescein isothiocyanate. In the presence of 
antibodies against Brucella spp., large fluorescent complexes are formed. 
In negative samples, the antigen remains uncomplexed. These smaller 
molecules spin more quickly and therefore cause greater depolarisation of 
the light than do the samples positive for Brucella spp. (Godfroid et al., 
2010; Banai et al., 2017).  
This test is capable of reducing but not fully eliminating the reactions 
due to residual antibody produced in response to vaccination (Nielsen et 
al., 1996, 2000; Gall et al., 2002). Moreover, the specificity of FPA in 
FPSR conditions is currently unknown in cattle and small ruminants, but it 
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has been clearly shown that it does not resolve the FPSR problem in swine 
(Praud et al., 2012). 
 
 
Native Hapten Test (NH) 
 
Native hapten (NH) are free polysaccharides, produced by at least B. 
melitensis and B. abortus that are almost or totally identical to the O-
polysaccharide. NH are suitable antigens for immunoprecipitation tests 
(Ducrotoy et al., 2016). In cattle, NH tests are highly specific in B. abortus 
S19 vaccination contexts and have been used successfully in combination 
with the RBT as a screening test (OIE, 2016). The optimal sensitivity 
(close to that of CFT but significantly lower than that of RBT and S-LPS 
based i-ELISAs) is obtained in a reverse radial immunodiffusion (RID) 
system in which the serum diffuses into a hypertonic gel containing the 
polysaccharide, but the double gel diffusion assay is also useful (Muňoz et 
al., 2005). 
These native hapten tests are also of interest to use in sheep and goats 
as they are very specific for discriminating the serological responses of 
infected animals (positive) from those induced in B. melitensis Rev.1 
vaccinated animals (usually negative after a given time post-vaccination). 
The optimal diagnostic sensitivity (around 90%) is obtained in the double 
gel diffusion or RID tests for sheep and goats, respectively (OIE, 2016). 
 
 
Lateral Flow Assay (LFA) 
 
The lateral flow assay (LFA) is a simplified version of ELISA 
consisting of a nitrocellulose detection strip, contain Brucella LPS as well 
as a Brucella-specific capture probe, flanked at one end by a reagent pad, 
consisting of a colloidal gold immune conjugate, and at the other end by an 
absorption pad. The flow assay is simply performed by the addition of 5 μl 
of serum directly onto the sample application pad, followed by the addition 
of some test liquid. The result is read 10 to 15 minutes later by visual 
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inspection for staining. The assay is based on the binding of specific 
antibodies present in the clinical specimen to LPS antigen and staining of 
the bound antibodies by a colloidal gold-labeled antibody conjugate (Smits 
et al., 2003). 
Abdoel et al. (2008) developed a lateral flow immunochromatography 
device for the serodiagnosis of brucellosis in cattle, goat, sheep and swine. 
The sensitivity of the bovine Brucella LFA was calculated to be 90%, that 
of the caprine LFA 100%, that of the ovine LFA 77%, and that of the 
swine LFA 73%. No reactivity in the Brucella LFAs was observed for 
samples from animals known to be free of brucellosis indicating a high 
(100%) specificity. 
 
 
Interferon-Gamma (IFN-γ) Release Assay 
 
The IFN-γ release assay involves stimulation of lymphocytes in whole 
blood with a suitable antigen such as brucellin. The resulting IFN-γ 
production is detected through a capture ELISA (OIE, 2016, 2018). This is 
a relatively sophisticated assay that is performed by mixing heparinized 
blood with brucellin (phosphate buffered saline is used as a negative 
control) followed by incubation. IFN-γ (an important cytokine in the 
response against Brucella) is then measured using an ELISA. The method 
was developed in an attempt to find alternative methods to identify FPSR 
animals. However, when studied in Yersinia enterocolitica O:9 and B. 
abortus infected cattle, it fails to provide satisfactory discrimination 
(Ducrotoy et al., 2016).  
 
 
Brucellin Skin Test (BST) 
 
An alternative immunological assay is the brucellin skin test (BST), 
which can be used for screening unvaccinated herds, provided that a 
purified (free of S-LPS) and standardized antigen preparation is used. This 
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antigen is a Brucella protein mixture containing up to 20 different proteins 
(Ducrotoy et al., 2016). 
The BST has a very high specificity, such that serologically negative 
unvaccinated cattle that are positive reactors to the brucellin test should be 
regarded as infected animals (Pouillot et al., 1997). This test also has a 
high sensitivity for the diagnosis of B. melitensis infection in small 
ruminants and, in the absence of vaccination, is considered one of the most 
specific diagnostic tests (OIE, 2016). 
Animals vaccinated with B. melitensis Rev.1, B. abortus S19 or RB51 
can give positive results in this test for years (De Massis et al., 2005). 
Although the BST is probably the most specific indirect assay for 
diagnosing brucellosis (in unvaccinated animals), the final diagnosis 
should not be made solely based on positive intradermal reactions given by 
a few animals in the herd and should be supported by a complementary 
diagnostic test. 
For sheep and goats, 0.1 mL of brucellin (2000 Units/mL) is injected 
intra-dermally into the lower eyelid, after 48 hours any visible or palpable 
reaction of hypersensitivity, such as an oedematous reaction leading to an 
elevation of the skin or thickening of the eyelid (≥ 2 mm), should be 
interpreted as a positive reaction (OIE, 2016). 
 
 
SENSITIVITY AND SPECIFICITY OF INDIRECT TESTS  
FOR BRUCELLOSIS DIAGNOSIS  
 
Diagnostic sensitivity (DSe) describes the ability of a test to detect the 
disease. Diagnostic specificity (DSp) indicates the accuracy of the test to 
detect non-diseased animals. 
B. melitensis and B. abortus S-LPS and core-O-polysaccharide are 
present in most currently used immunological tests. This antigen is highly 
effective for detecting the presence of specific antibodies, such as S-LPS, 
which is immunodominant in the antibody response, and O-polysaccharide 
antibodies, as the respective epitopic density of the antigene is high. On the 
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other hand, Brucella O-polysaccharide cross-reacts with other gram-
negative bacteria, mainly Yersinia enterocolitica serotype O:9, which 
generates the strongest cross-reactivity, and other bacteria such as 
Escherichia coli 0157 and the Salmonella group N (O:30). None of the 
above-mentioned tests are Brucella species specific. Nevertheless, some of 
those methods, specifically buffered agglutination tests, set a high standard 
with regards to the DSe/DSp if no vaccination is practiced or when the 
FPSR is not significant. These tests are very inexpensive. When 
interference of vaccination is expected, a cautious use of the smooth 
vaccines combined with NH immunoprecipitation or c-ELISA testing 
remain as the best strategy available (Ducrotoy et al., 2016). 
The sensitivity and specificity of diagnosis tests of brucellosis are 
presented in Table 8.2. The i-ELISA and FPA proved to be the most 
sensitive, while the highest specificity was determined for the brucellin 
skin test, CFT and also, i-ELISA. The less specific was the MRT. 
 
Table 8.2. Sensitivity and specificity of indirect tests for the diagnosis 
of cattle brucellosis. Adapted from Godfroid et al. (2010) 
 
Tests Sensitivity (%) Specificity (%) 
Serological tests 
SAT (SAW)/MAT 81.5 98.9 
CFT 90-91.8 99.7-99.9 
BBAT 87 97.8 
i-ELISA 97.2 97.1-99.8 
c-ELISA 95.2 99.7 
FPA 96.6 99.1 
Milk tests 
MRT 88.5 77.4 
FPA 76.9 100 
i-ELISA 98.6 99.0 
Cellular tests   
Brucellin Skin test 78-93 99.8 
Abbreviations: slow agglutination test (SAT); slow agglutination of wright (SAW); micro agglutination 
test (MAT); complement fixation test (CFT); buffered Brucella antigen test (BBAT); indirect 
ELISA (I-ELISA); competitive ELISA (C-ELISA); fluorescence polarization assay (FPA); milk 
ring test (MRT).  
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A 100% DSp is displayed by i-ELISA, with S-LPS or OPS-core 
antigenes, in Brucella-free animals not exposed to Y. enterocolitica O:9, 
though they offer poor DSp in cattle exposed experimentally to Y. 
enterocolitica O:9 or from herds with FPS. To circumvent the FPSR 
problem, the approach may be the use of cellular immunity tests, in which 
antigen is a cellular fraction consisting of non-denatured water-soluble 
proteins resulting in superb DSp in the skin test, in the absence of 
vaccination. Although its DSp is excellent, the protein skin test is only 
useful at herd level and requires two consecutive visits to herds (Ducrotoy 
et al., 2016, 2018).  
Although no current serological test provides enough DSe for the 
100% DSp required, some test combinations can be helpful. According to 
Ducrotoy et al. (2018), the best test when DSe/DSp balances are 
considered is the reverse radial immunodiffusion-native hapten (RID-NH)  
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